leisure time -WSS

leisure time

author：focus 2025-09-30 12:57:17 - browse：7155

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

In an abrupt change of course from plans earlier in the month, at-home test maker Cue Health is laying off all of its employees and shutting down as of Friday, May 24.

The company, which grew to prominence during the Covid-19 pandemic as the maker of one of the only molecular at-home tests for the virus, has been teetering on the edge of insolvency for months. The shutdown, first reported by the San Diego Union-Tribune, comes just over a week after the FDA warned consumers not to use Cue’s only FDA-authorized product, a Covid-19 test kit.

Cue had previously notified 49% of its workers on May 1 that they would be laid off from the company, effective July 1. But in a WARN notice filed with California state regulators on May 20, chief human resources officer Allison Blackwell said that due to the “fluid nature of this situation,” all U.S. employees who had not already received notice of termination would be receiving one. All employees will receive their last paychecks on May 24, the notice said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Fauci's latest grilling in Congress: 9 hours, behind closed doors

focus

Wikipedia

leisure time

WSS

TB outbreak tied to bone grafts underscores testing shortcomings

Male doctors called my cancer incurable. A female doctor showed it wasn't

Study suggests new cause of Down syndrome: cells linked to aging

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Ascension's ugly legal battle over care for poor patients in Texas

At JPM 2024, hospital systems pitch financial strength to investors

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

Alkermes shareholders re

The history of OxyContin, told through Purdue Pharma documents

Duchenne breakthrough therapy leaves behind pioneering families

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Activists slam private health insurers over coverage restrictions

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

Sports medicine is finally prioritizing gender equality

After John Oliver segment, STAT readers share their opioid

leisure time

White House drug shortages task force keeps mum with Congress

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

Stories you might have missed in 2023: health, science, medicine

Boston Scientific acquires urology company Axonics for $3.7 billion

Fauci's latest grilling in Congress: 9 hours, behind closed doors

focus

Wikipedia

leisure time

hotspot